Dr. Clare Tempany, MD, is a professor of Radiology at Harvard Medical School. She is the Ferenc Jolesz Chair of Radiology Research at the Department of Radiology, Brigham & Women's Hospital and she is a diagnostic radiologist. She is the Principal Investigator of the P41 National Center of Image Guided Therapy (NCIGT) grant and the Medical Director of the Advanced Multimodal Image-Guided Operating (AMIGO) suite.
Dr. Tempany is an expert in Body MRI, specifically, Pelvic MRI. Her research interests include Pelvic Oncology, specifically, prostate cancer. She leads a large Prostate Research Program, which includes diagnostic, staging, and MR/US guided interventions (biopsy) and treatment guidance programs. Other interests are in image-guided therapy including computer-assisted technology development for multi-modal image display in the operating room.
Since 2000 she has been an active investigator in multiple trials of clinical MR-guided Focused Ultrasound Surgery (MRgFUS). She has completed three trials in the use of MRgFUS for treatment of uterine fibroids and an on-going trial for treatment of Metastatic bone tumors for palliation of pain. Using the device ExAblate 2000, the data resulted in FDA approval of the device in October 2004.